What if we could reprogram aging cells in our body to fight disease and
enhance health?
CellRep pioneers dynamic cell reprogramming without gene editing, revolutionizing the way cell therapies are developed and applied. Our AI-powered platform discovers and validates compounds that optimize cellular function, tackling three critical limitations of current CAR-T therapies: low efficacy in solid tumors, long manufacturing times, and cost-prohibitive treatments. We are making personalized medicine scalable—starting with cancer therapies and expanding into longevity applications.
Our Approach
End-to-end pipeline from target discovery to preclinical validation of cell reprogramming strategies.
Cells are nature's supercomputers
A universe of opportunities holding the key to enhance our health.
Our Technology and Platform
We have developed an innovative approach to enhance T cell functionality by reprogramming these cells to a rejuvenated state and with improved therapeutic potential.
Our platform includes:
In vitro Screening
Every cell therapy faces unique challenges during delivery. CellRep’s discovery platform identifies the optimal intracellular targets and candidate compounds to optimize cellular profiles and maximize therapeutic efficacy. Our methodology not only identifies, tests, and protects molecules, but also develops tailored best practices for each cell therapy manufacturer.
Meet our brilliant team
Our team is built of experienced immunologists, biochemists and bioinformatic engineers working together to deliver the best solutions to improve current and future cell therapies.
